Sanofi's Dengue Vaccine Gets FDA Approval -- Update

Date : 02/05/2019 @ 04h16
Source : Dow Jones News
Valeur : Sanofi (SNY)
Cours : 45.48  -0.08 (-0.18%) @ 16h17
Sanofi Cours Graphique

Sanofi's Dengue Vaccine Gets FDA Approval -- Update

Sanofi (NASDAQ:SNY)
Graphique Historique de l'Action

6 Mois : De Avr 2019 à Oct 2019

Plus de graphiques de la Bourse Sanofi
By Maria Armental 

Sanofi SA's dengue vaccine was approved in the U.S., the first treatment cleared by American regulators to protect against the mosquito-borne viral infection.

The vaccine, Dengvaxia, was approved by the Food and Drug Administration to treat people aged 9 to 16 with a laboratory-confirmed prior infection who live in areas where the disease occurs regularly through the year.

Dengvaxia was first approved in Mexico in 2015 and remains the world's only approved vaccine against dengue. But safety fears have complicated efforts to contain the growing global threat. World Health Organization estimates put about half the world's population at risk.

In late 2017, Sanofi said post-marketing data showed those who haven't been infected before may have a higher risk of severe dengue disease if they become infected after vaccination.

The Philippines, which was the first country to widely distribute the vaccine, revoked its product-license approval this year after a number of deaths were reported.

The virus causes a severe flu-like illness, but it can develop into severe dengue, which is potentially deadly. It is typically found in tropical and sub-tropical climates.

Though not common in the U.S., several U.S. territories are prone to outbreaks, including Puerto Rico, the U.S. Virgin Islands, American Samoa and Guam.

The disease is hard to vaccinate against because it can be caused by four strains of the same virus. Dengvaxia targets the four strains.

Other vaccines are being developed, including Takeda Pharmaceutical Co.'s TAK-003, which has shown promising results in a key trial.

Write to Maria Armental at maria.armental@wsj.com

 

(END) Dow Jones Newswires

May 01, 2019 22:01 ET (02:01 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Dernières Valeurs Consultées
EU
GLE
Société Gé..
EU
ALU
ALCATEL-LU..
EU
PX1
CAC 40
ORA
Orange
FX
EURUSD
Euro vs Do..
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.


Inscrivez-vous maintenant pour créer votre liste d'actions personnalisée, en streaming.

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V:fr D:20191016 14:32:44